Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
Jerel Davis, insider at Chinook Therapeutics
Jerel Davis Insider Alerts

Get notified the next time Jerel Davis buys or sells Chinook Therapeutics stock. Enter your email address below to get our daily insider buying and selling report.

Jerel Davis Insider Information

Jerel Davis, Ph.D., is a Managing Director based in Vancouver, Canada. Since joining Versant in 2011, he has been involved in launching and investing in a number of Versant’s portfolio companies including Quanticel (sale), Novira (sale), Crispr (2016 IPO), Inception 4 (sale), Inception 5 (sale), Northern, Turnstone, BlueRock, Repare, VenatoRx and Akero. He has led Versant’s execution of creative corporate transactions with multiple pharmaceutical partners including Celgene, Roche and Bayer, and was instrumental in establishing Versant’s presence in Canada, including the creation of our company-building infrastructure in Vancouver, Toronto and Montreal. Jerel was promoted to Managing Director at Versant in 2015.

Prior to joining Versant, Jerel was Associate Principal at McKinsey and Company where he advised healthcare corporations in pharmaceuticals, biotechnology, medical device and molecular diagnostics. He has worked in a number of healthcare markets globally including the U.S., Europe, China, Russia and India. Jerel earned his doctorate from Stanford University, where he also completed his post-doctoral research.

How do I contact Jerel Davis?

The corporate mailing address for Dr. Davis and other Chinook Therapeutics executives is 740 HEINZ AVENUE, BERKELEY CA, 94710. Chinook Therapeutics can also be reached via phone at (206) 485-7051 and via email at [email protected]

Has Jerel Davis been buying or selling shares of Chinook Therapeutics?

Jerel Davis has not been actively trading shares of Chinook Therapeutics within the last three months. Most recently, Davis Jerel sold 850,000 shares of the business's stock in a transaction on Friday, August 27th. The shares were sold at an average price of $14.00, for a transaction totalling $11,900,000.00.

Who are Chinook Therapeutics' active insiders?

Chinook Therapeutics' insider roster includes Srinivas Akkaraju (Director), Jerel Davis (Director), Eric Dobmeier (CEO), and Alan Glicklich (Insider).

Are insiders buying or selling shares of Chinook Therapeutics?

In the last twelve months, Chinook Therapeutics insiders bought shares 6 times. They purchased a total of 1,435,500 shares worth more than $19,654,930.00. In the last twelve months, insiders at the sold shares 8 times. They sold a total of 1,445,000 shares worth more than $20,279,981.30. The most recent insider tranaction occured on November, 15th when Director Srinivas Akkaraju bought 1,215,000 shares worth more than $17,010,000.00. Insiders at Chinook Therapeutics own 29.8 % of the company.

Information on this page was last updated on 11/15/2021.

Jerel Davis Insider Trading History at Chinook Therapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/27/2021Sell850,000$14.00$11,900,000.00View SEC Filing Icon  
See Full Table

Jerel Davis Buying and Selling Activity at Chinook Therapeutics

This chart shows Davis Jerel's buying and selling at Chinook Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Chinook Therapeutics Company Overview

Chinook Therapeutics logo
Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA.
Read More

Today's Range

Now: $15.16
Low: $14.99
High: $15.68

50 Day Range

MA: $13.77
Low: $10.74
High: $16.83

2 Week Range

Now: $15.16
Low: $10.48
High: $21.68

Volume

304,345 shs

Average Volume

655,768 shs

Market Capitalization

$683.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!